what is the high blood pressure medicine being recalled?
94652
NMBA is a "potential human carcinogen," the FDA says. The recall comes amid a larger string of recalls of blood pressure medications valsartan, losartan and irbesartan that contain trace levels of carcinogens NMBA, N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), the FDA says.
1435462
Not all Camber valsartan products distributed in the U.S. are being recalled. Camber Pharmaceuticals is recalling certain valsartan tablets because they contain the impurity N-nitrosodimethylamine (NDMA) in the active pharmaceutical ingredient (API).
381696
If you're diagnosed with high blood pressure, your doctor may recommend taking 1 or more medicines to keep it under control. These come as tablets and usually need to be taken once a day. Common blood pressure medicines include: ACE inhibitors – such as enalapril, lisinopril, perindopril and ramipril.
1069620
Lupin Pharmaceuticals Issues Recall for Blood Pressure Meds. The FDA announced that Lupin Pharmaceuticals has pulled a lot of its lisinopril 20mg and hydrochlorothiazide 12.5mg tablets, following a complaint regarding a foreign drug tablet.
1261926
On October 25, 2019, AvKare announced the voluntary, consumer-level recall of prescription ranitidine due to potential contamination with N-nitrosodimethylamine (NDMA). AvKare's recall is due to the recent consumer level recall of Dr. Reddy's ranitidine products.
621826
Following a report of a metal contaminant found in a tablet, Lupin Pharmaceuticals Inc. is pulling 11,706 bottles of 10-mg lisinopril tablets, USP. The recall appears in the August 22, 2018, US Food and Drug Administration (FDA) Enforcement Report.
917492
Benicar Recall To date, the FDA nor Daiichi Sankyo, the maker of low blood pressure treatment medication, has yet to recall Benicar due to its link with causing sprue-like enteropathy.
842431
This week, the drug companies Novartis (through its generic division, Sandoz) and Apotex announced that they were recalling all of their generic ranitidine products sold in the US.
620349
Hypertension Drug Recalled. Lupin Pharmaceuticals Inc. is recalling more than 11,000 bottles of 20-mg lisinopril tablets after a customer reported finding 10-mg tablets in two sealed 20-mg tablet bottles. The recall was included in the April 29, 2020, US Food and Drug Administration (FDA) Enforcement Report.
620249
Additional prescription and over-the-counter ranitidine drugs, including Zantac, are being recalled by Sanofi Consumer Health Inc., Sivem Pharmaceuticals ULC and Teva Canada Limited because they may contain the impurity N-nitrosodimethylamine (NDMA) above acceptable levels.
1238299
Blood Pressure Drug Recalled. Teva Pharmaceuticals USA is recalling 181,456 bottles of olmesartan medoxomil and hydrochlorothiazide tablets, 40 mg/25 mg, after samples failed to meet dissolution specifications, according to the January 23, 2019, US Food and Drug Administration (FDA) Enforcement Report.
478373
The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day or 0.32 parts per million for ranitidine).
786278
Health Canada investigating possible presence of cancer-causing chemical. Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.
409488
Lannett Ranitidine Recall On October 28, 2019 the FDA announced that Lannett Company, Inc. recalled all lots of its prescription ranitidine syrup. The recall includes Lannett's ranitidine oral solution prescribed in 15mg/mL doses due to the confirmed presence of NDMA.
450314
In terms of dollar sales, recent statistics put the angiotensin II receptor blocker valsartan (Diovan) in the lead for high blood pressure medications, followed by the beta blocker metoprolol, the generic combination of valsartan and HCTZ, olmesartan (Benicar), and olmesartan and HCTZ (Benicar HCT).
184829
In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. Date 06/2020.
1078318
April 2020 update: The FDA has recalled all over-the-counter and prescription forms of ranitidine, which includes Zantac. If you take ranitidine, contact your health care provider to discuss other treatment options.